Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of Ultibro Breezhaler in healthy subjects
NCT04856098Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- May 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of indacaterol and glycopyrronium, sponsored by Orion Corporation. Primary endpoint: Peak indacaterol concentration in plasma. Started May 2021; status: completed.
02
Drugs
indacaterolglycopyrronium
Beyond the preview
Go deeper on NCT04856098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04856098.